Jamie Elvidge

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Clinical Practice

Randomized Controlled Trial

Systematic Review

Top Venues

International journal of technology assessment in health care

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Jamie Elvidge, Ashley Summerfield, Saskia Knies, Bertalan Németh, Zoltán Kaló, Wim G Goettsch, Dalia M Dawoud, null null
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International journal of technology assessment in health care 39 (1) (2023)
Jamie Elvidge, Ashley Summerfield, Saskia Knies, Bertalan Németh, Zoltán Kaló, Wim G Goettsch, Dalia M Dawoud, null null
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International journal of technology assessment in health care 39 (1) (2023)
Jamie Elvidge, Ashley Summerfield, Saskia Knies, Bertalan Németh, Zoltán Kaló, Wim G Goettsch, Dalia M Dawoud, null null
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International journal of technology assessment in health care 39 (1) (2023)
Jamie Elvidge, Ashley Summerfield, Saskia Knies, Bertalan Németh, Zoltán Kaló, Wim G Goettsch, Dalia M Dawoud, null null
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International journal of technology assessment in health care 39 (1) (2023)
Jamie Elvidge, Dalia M Dawoud
Assessing Technologies for COVID-19: What are the Challenges for Health Technology Assessment Agencies? Findings From a Survey and Roundtable Workshop. PharmacoEconomics 39 (12) (2021)
Gemma Elizabeth Shields, Rebekah Pennington, Ash Bullement, Stuart James Wright, Jamie Elvidge
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time. PharmacoEconomics (2021)